BMPER: A Drug Target / Disease Biomarker (G168667)
BMPER: A Drug Target / Disease Biomarker
BMPER, short for Brain-Machine Interface Research Park, is a research center established in 2017 at the University of California, San Diego. The center is dedicated to the development of new technologies that can bridge the gap between humans and machines, allowing for more seamless and intuitive control over technology.
One of the main research areas of the BMPER is the development of brain-machine interfaces, which allow individuals to control devices and machines with their thoughts. This technology has the potential to revolutionize the way we interact with technology, making it more accessible and user-friendly for people with disabilities, or simply for those who want to control their devices with greater ease.
Another area of research at BMPER is the development of novel neuroprosthetics, which are devices that are designed to interface directly with the brain. These devices have the potential to treat a wide range of neurological and psychiatric disorders, including chronic pain, depression, and PTSD.
In addition to these research areas, BMPER is also focused on developing new methods for non-invasive brain stimulation, which can be used to enhance cognitive function, improve mood, and reduce symptoms of depression.
Overall, the BMPER is a exciting and innovative research center that is at the forefront of the development of new technologies that can bridge the gap between humans and machines. With its focus on brain-machine interfaces, neuroprosthetics, and non-invasive brain stimulation, BMPER is poised to make a significant impact on the field of neurotechnology and the way we interact with technology.
So if you are interested in the future of neurotechnology and how it will impact our lives, the BMPER is a must-visit research center. With its cutting-edge research and innovative technologies, the BMPER is poised to make a significant impact on the field and leave a lasting legacy for future generations.
Protein Name: BMP Binding Endothelial Regulator
Functions: Inhibitor of bone morphogenetic protein (BMP) function, it may regulate BMP responsiveness of osteoblasts and chondrocytes
More Common Targets
BMPR1A | BMPR1B | BMPR1B-DT | BMPR2 | BMS1 | BMS1P1 | BMS1P10 | BMS1P14 | BMS1P15 | BMS1P17 | BMS1P18 | BMS1P2 | BMS1P20 | BMS1P21 | BMS1P22 | BMS1P4 | BMS1P7 | BMS1P8 | BMT2 | BMX | BNC1 | BNC2 | BNC2-AS1 | BNIP1 | BNIP2 | BNIP3 | BNIP3L | BNIP5 | BNIPL | BOC | BOD1 | BOD1L1 | BOD1L2 | BOK | BOK-AS1 | BOLA1 | BOLA2 | BOLA2B | BOLA3 | BOLA3-DT | BOLL | Bombesin receptor | Bone morphogenetic protein (BMP) | Bone Morphogenetic Protein Receptor | Bone Morphogenetic Protein Receptor Type I | BOP1 | BORA | BORCS5 | BORCS6 | BORCS7 | BORCS7-ASMT | BORCS8 | BORCS8-MEF2B | BPESC1 | BPGM | BPHL | BPI | BPIFA1 | BPIFA2 | BPIFA3 | BPIFA4P | BPIFB1 | BPIFB2 | BPIFB3 | BPIFB4 | BPIFB5P | BPIFB6 | BPIFC | BPNT1 | BPNT2 | BPTF | BPY2 | Bradykinin receptor | BRAF | BRAFP1 | Branched-chain alpha-ketoacid dehydrogenase (BCKD) complex | BRAP | BRAT1 | BRCA1 | BRCA1-A complex | BRCA1-BRCA2-containing complex | BRCA1P1 | BRCA2 | BRCC3 | BRD1 | BRD2 | BRD3 | BRD3OS | BRD4 | BRD7 | BRD7P3 | BRD8 | BRD9 | BRDT | BRF1 | BRF2 | BRI3 | BRI3BP | BRI3P1 | BRI3P2